|
|
|
|
|
by munk-a
2233 days ago
|
|
> The problem is that we can’t just snap our fingers and make tens of millions of tests appear out of thin air. You are correct - but we (or rather the government) can snap it's fingers and compel some private companies that are well positioned to be able to manufacture tests to do so at a higher priority than other business concerns - or we (again the government) can issue generous contracts for testing supplies that guarantees payment to private companies manufacturing them even if the original quota of tests requested by the government is above the level we end up needing. I think that large countries actually have an advantage here - a small country might not have any internal industry that'd be capable of manufacturing tests without heavy retooling - or that industry might be so small and specialized that scaling it up is infeasible. But even in that sort of a situation they can use market based solutions to bid on tests in a manner that motivates private companies in other countries to feel confident committing to test production - and that's only needed if there isn't any sort of altruistic world-banding-together-to-fight-the-issue effort. |
|
And we’ve done that with things like masks and ventilators. But there is a key limiting factor with the tests, the reagant supply. Again, can’t just snap our fingers and make it happen faster. This isn’t AWS, we can’t just spin up more supply in an instant.